Overview
Key stats
Fundamentals Sep 12- Open
- $257.10
- 52-wk high
- $271.80
- High
- $258.14
- 52-wk low
- $154.50
- Low
- $254.21
- Prev close
- $259.21
- Mkt cap
- $42.59B
- P/E
- 32.2x
- Volume
- 1.09M
- Fwd P/E
- 17.7x
- Beta
- 1.19
- P/S
- 2.5x
- P/B
- 6.9x
- Profit margin
- +8.1%
- Op margin
- +13.0%
- ROE
- +22.8%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 1.1% above what analysts expected.
Earnings per share
$2.72 expected
Revenue
No comparable estimate
Company adjusted EPS
From the company's release
The company and the analyst consensus count earnings differently, so the two figures differ. The comparison above uses the analyst basis.
Full-year 2026 guidance
$17.27B to $17.48B
No comparable estimate
Reports Oct 27, 2026, in 44 days
EPS expected
$3.22 to $3.54
Revenue expected
14 analysts
Last 30 days
Analysts raising estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $4.10B | $4.36B | $4.15B | $4.37B |
| Cost of what it sold | $2.73B | $4.07B | $2.80B | $2.93B |
| Gross profit | $1.37B | $292.0M | $1.35B | $1.44B |
| What it spent | ||||
| Sales and admin | $514.0M | $468.0M | $502.0M | $574.0M |
| Other operating costs | $306.0M | -$908.0M | $339.0M | $355.0M |
| Total operating expenses | $820.0M | -$440.0M | $841.0M | $929.0M |
| What was left | ||||
| Operating profit | $553.0M | $732.0M | $514.0M | $506.0M |
| Interest on debt | $189.0M | $193.0M | $192.0M | $197.0M |
| Profit before tax | $408.0M | $572.0M | $328.0M | $301.0M |
| Tax | $76.0M | $58.0M | $59.0M | $60.0M |
| Net profit | $331.0M | $514.0M | $274.0M | $256.0M |
| EBITDA | $883.0M | $1.05B | $808.0M | $790.0M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
IQVIA Announces Pricing of Senior Notes - September 9, 2026
NeutralSep 10IQVIA stock rises amid $2 billion senior notes offering By Investing.com
BullishSep 9IQVIA Announces Pricing of Senior Notes
NeutralSep 9IQVIA Holdings Inc. Announces Pricing of $2,000,000,000 Senior Notes Due 2034
Leans bullishSep 9IQVIA Announces Offering of Senior Notes - September 9, 2026
NeutralSep 9Earnings Preview: Veracyte (VCYT) Q2 Earnings Expected to Decline
NeutralSep 8Novartis India to acquire Pfizer's 'Minipress' trademark for ₹1,250 crore
NeutralSep 7IQVIA Holdings EVP James G. Berkshire Executes Stock Appreciation Rights and Sells Shares
NeutralSep 4
Macro
32 macro signals shaping IQV right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results